Iltamiocel not checked

Cook MyoSite

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 3 trial completes
Trials
2 active
6 in total
Targets
—
None known yet

What this is

How it works
A cell therapy: living cells given to the patient as the treatment.-cel: cell therapies WHO name stem
How it’s given
“Autologous Muscle Derived Cells for Urinary Sphincter Repair (generic name: iltamiocel)”In the company’s words, NCT03104517 on ClinicalTrials.gov
Tested for
Stress Urinary Incontinence, Fecal Incontinence
Main trialPhase 3
“This study evaluates the efficacy and safety of Autologous Muscle Derived Cells for Urinary Sphincter Repair (AMDC-USR; generic name: iltamiocel) compared to a placebo in the reduction of stress incontinence episode frequency in adult female patients with post-surgical persistent or recurrent stress urinary incontinence (SUI). Half of the participants will receive AMDC-USR (injections with cells) and the other half will receive placebo.”In the company’s words, NCT03104517 on ClinicalTrials.gov
Other names
AMDC-USR · AMDC

Other drugs for Stress Urinary Incontinence

All 3 drugs for Stress Urinary Incontinence

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials6

TrialPhaseCompletesWhat it tests
Phase 3Active, not recruiting 11 Jun 2026 Autologous Muscle Derived Cells Compared to Placebo for Urinary Sphincter Repair in Post-surgical Female Stress Incontinence
Phase 3Active, not recruiting Dec 2026 Iltamiocel Compared to Placebo for Chronic Fecal Incontinence in Females With Obstetric Injury
Phase 3Completed 1 Nov 2019 Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Phase 3Withdrawn Jun 2026 Japanese Bridging Study of Autologous Muscle Derived Cells Compared to Placebo for Female Urinary Sphincter Repair(JPN1)
Phase 1/2Terminated 12 Dec 2012 Autologous Cell Therapy for Ischemic Heart Failure
Phase 1/2Completed 27 Oct 2021 Autologous Cell Therapy for Treatment of Fecal Incontinence
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow Iltamiocel

Following is part of Solo: you see every change to Iltamiocel the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in